Trial Profile
Phase 2a dose escalation trial of Mipsagargin in East Asian patients with Hepatocellular Carcinoma
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 21 Mar 2016
Price :
$35
*
At a glance
- Drugs Mipsagargin (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Inspyr Therapeutics
- 20 Nov 2015 New trial record